ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 628

Poor Prognosis of Patients with Primary Sjögren Syndrome Who Fulfilled at Diagnosis the Classification Criteria for Concomitant Cryoglobulinemic Vasculitis

Soledad Retamozo1,2, Hoda Gheitasi3, Luca Quartuccio4, Belchin Kostov5, Laura Corazza4, Albert Bové3, Antoni Sisó-Almirall5, Myriam Gandía3, Manuel Ramos-Casals1, Salvatore De Vita6 and Pilar Brito-Zerón1, 1Department of Autoimmune Diseases, CELLEX-IDIBAPS, Hospital Clínic, Barcelona, Barcelona, Spain, 2Rheumatology Unit, Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, 3Department of Autoimmune Diseases, IDIBAPS, Hospital Clínic, Barcelona, Spain, 4S. Maria della Misericordia, University of Udine, Italy, Udine, Italy, 5Primary Care Research Group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Primary Care Centre Les Corts, CAPSBE, Barcelona, Spain, 6Santa Maria della Misericordia Hospital, University of Udine, Udine, Italy

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cryoglobulinemia, death and vasculitis, Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Sjögren's Syndrome Poster I: Clinical Insights into Sjögren's Syndrome

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

To evaluate the fulfilment of classification criteria for cryoglobulinemic vasculitis (CV) at diagnosis in a large cohort of patients with primary Sjögren syndrome (SS) and their correlation with poor outcomes.

Methods:

We included 515 consecutive patients tested for serum cryoglobulins who fulfilled the 2002 classification criteria for primary SS. CV classification criteria and serum cryoglobulins at diagnosis were assessed as predictors of death and lymphoma using Cox proportional-hazards regression analysis adjusted for age and gender.

Results:

Positive serum cryoglobulins were detected in 65 (12%) patients, of whom 21 (32%) fulfilled CV classification criteria. Patients with CV had a higher frequency of type II cryoglobulinemia (86% vs. 43%, p=0.04), a higher mean cryocrit level (6.58% vs. 1.25%, p<0.001), and a higher cumulated mean ESSDAI score (35.3 vs. 16.2, p<0.001) in comparison with patients carrying serum cryoglobulins who did not fulfill CV criteria. After a mean follow-up of 110 months, 45 (9%) patients developed B-cell lymphoma and 33 (6%) died. In comparison with patients without cryoglobulinemia, patients with cryoglobulins showed a high risk of development of B-cell lymphoma; the risk was higher for those who fulfilled the CV criteria (HR 7.47, CI95% 3.38-16.53) than for those who did not fulfill the CV criteria (HR 2.56, CI95% 1.03-6.35); statistical differences were found in the univariate analysis, but were not confirmed by the multivariate models. With respect to mortality, patients with CV had a higher risk of death in both the univariate (HR 11.68, CI95% 4.44-30.74) and multivariate (HR 4.36, CI95% 1.32-14.47) adjusted models in comparison with those without cryoglobulins. 

Conclusion:

Patients with primary SS who fulfilled the classification criteria for cryoglobulinemic vasculitis at diagnosis are at higher risk of death.


Disclosure: S. Retamozo, None; H. Gheitasi, None; L. Quartuccio, None; B. Kostov, None; L. Corazza, None; A. Bové, None; A. Sisó-Almirall, None; M. Gandía, None; M. Ramos-Casals, Bristol-Myers Squibb, 2; S. De Vita, None; P. Brito-Zerón, None.

To cite this abstract in AMA style:

Retamozo S, Gheitasi H, Quartuccio L, Kostov B, Corazza L, Bové A, Sisó-Almirall A, Gandía M, Ramos-Casals M, De Vita S, Brito-Zerón P. Poor Prognosis of Patients with Primary Sjögren Syndrome Who Fulfilled at Diagnosis the Classification Criteria for Concomitant Cryoglobulinemic Vasculitis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/poor-prognosis-of-patients-with-primary-sjogren-syndrome-who-fulfilled-at-diagnosis-the-classification-criteria-for-concomitant-cryoglobulinemic-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/poor-prognosis-of-patients-with-primary-sjogren-syndrome-who-fulfilled-at-diagnosis-the-classification-criteria-for-concomitant-cryoglobulinemic-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology